BPC-157 clears from circulation in under 30 minutes due to its short half-life, yet the cellular repair processes it initiates persist well beyond active administration
Clinical Evidence : Multiple meta-analyses show a small but statistically significant reduction in body weight (approximately 1.1 to 2.0 lbs), waist circumference, and body fat percentage compared to placebo
Through its selective action on adipose tissue and beta-3 adrenergic receptors, this peptide stimulates lipolysis and fat oxidation without triggering the appetite changes, glucose disruptions, or hormonal alterations commonly associated with weight loss interventions
Preclinical research demonstrated that glucagon like peptide 1 (GLP-1) is locally synthesized in taste bud cells in the tongue and that GLP-1 receptor exists on the gustatory nerves in close proximity to GLP-1 containing taste bud cells
reported that treatments with ARB and IGF-1 enhanced Trolox-equivalent antioxidant capacity and increased levels of antioxidant enzymes (Tanaka et al., 2024)